Omeprazole (A2845) in Gastric Acid Secretion Research: Technical Applications

What This Product Solves

Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor specifically formulated for laboratory research into gastric acid secretion mechanisms, antiulcer activity models, and peptic ulcer disease workflows. Its validated inhibitory action on proton pumps (IC50: 5.8 μM) enables reproducible investigation of acid regulation pathways, with a distinct efficacy against histamine-induced acid formation (IC50: 0.16 μM). The chemical profile—3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide—offers high selectivity and purity (approximately 98%), supporting robust mechanistic studies. This compound is not intended for diagnostic or medical applications and should not be substituted where aqueous formulations are required.

This product directly addresses the need for a reliable gastric acid secretion inhibitor in preclinical and mechanistic research, especially where precise control of proton pump activity is paramount. For foundational setup and advanced workflow integration, refer to the internal article "Omeprazole (A2845): Protocols for Gastric Acid Research Workflows", which details protocol alignment and key storage considerations. For a focused review of assay design and inhibitor integration, see "Technical Guide: Using Omeprazole (A2845) in Gastric Acid Research".

Protocol Parameters

• Assay: Proton pump inhibition
  Value: IC50 = 5.8 μM
  Applicability: Suitable for in vitro H+,K+-ATPase activity assays and mechanistic antiulcer models.
  Rationale: Enables quantifiable suppression of gastric acid secretion via proton pump inhibition.
  Source: Omeprazole
• Assay: Histamine-induced acid formation
  Value: IC50 = 0.16 μM
  Applicability: Use in histamine-stimulated gastric acid secretion research and antiulcer activity studies.
  Rationale: Provides sensitive inhibition, allowing discrimination of compound selectivity in cellular and tissue-based assays.
  Source: Omeprazole
• Assay: Compound preparation and storage
  Value: Dissolve ≥17.27 mg/mL in DMSO; store solid at -20°C
  Applicability: Required for all workflows; aqueous and ethanol solvents are unsuitable.
  Rationale: Ensures compound stability and prevents precipitation or degradation; long-term solution storage not recommended.
  Source: Omeprazole
• Assay: Final working concentration selection
  Value: Typical range: 0.2–10 μM (workflow recommendation)
  Applicability: For dose-response studies in gastric acid secretion research; adjust according to assay sensitivity.
  Rationale: Balances efficacy and cytotoxicity in cell-based or ex vivo models.
  Source: Workflow recommendation

Workflow Setup and QC Checklist

• Compound Handling: Weigh Omeprazole powder (protected from light and moisture). Prepare fresh DMSO stock at the required concentration, ensuring complete dissolution by vortexing and brief sonication if needed.
• Solubility Validation: Confirm full solubilization visually; do not use if visible particulates remain. Avoid use of water or ethanol as solvents due to insolubility and risk of assay interference.
• Aliquoting and Storage: Dispense single-use aliquots to minimize freeze-thaw cycles. Store solid material at -20°C in a desiccated environment. Avoid storing DMSO solutions for extended periods; prepare fresh for each experiment.
• Assay Controls: Include vehicle controls (DMSO alone) and, where applicable, positive controls for gastric acid inhibition to benchmark assay performance.
• Shipping and Receipt: Confirm product arrives with blue ice packaging and inspect for temperature deviation. Do not use if signs of moisture exposure or improper storage are detected.
• Purity and Identity Check: Reference batch-specific COA for purity (~98%) and confirm molecular weight (345.42) via LC-MS or equivalent if required by protocol.

Common Failure Modes and Fixes

• Precipitation in Working Solutions: If precipitation occurs after dilution into assay buffer, confirm that DMSO content does not fall below solubility threshold. Increase DMSO in the vehicle (within assay tolerance limits) or prepare new stock.
• Loss of Activity: Decreased inhibitor efficacy may result from repeated freeze-thaw cycles or prolonged solution storage. Use aliquoted stock and prepare fresh solutions for each experiment.
• Assay Variability: Variability in gastric acid secretion endpoints can arise from inconsistent compound preparation or inadequate controls. Standardize stock preparation, use matched vehicle controls, and validate assay sensitivity with known inhibitors.
• Compound Degradation: Exposure to moisture, light, or suboptimal temperatures may reduce compound stability. Always store under recommended conditions and discard any material showing discoloration or clumping.
• Incompatibility with Aqueous Systems: Attempting to dissolve Omeprazole in water or ethanol will result in poor solubility. Use only DMSO as the solvent for stock solutions.

Scope and Limitations

Omeprazole (A2845) is intended solely for scientific research into gastric acid secretion, antiulcer activity, and related preclinical workflows. It is not validated for diagnostic, therapeutic, or any clinical use. Due to its insolubility in aqueous and ethanol-based solutions, it is unsuitable for protocols requiring such solvents. Furthermore, long-term storage of prepared solutions is not recommended as stability may be compromised. For research designs requiring in vivo formulations or diagnostic-grade validation, alternative products or methods should be considered.

For protocol design and troubleshooting in peptic ulcer disease models, see the internal guide "Technical Guide: Using Omeprazole (A2845) in Gastric Acid Research". For a broader overview of workflow protocols and storage, refer to "Omeprazole (A2845): Protocols for Gastric Acid Research Workflows".

Conclusion

Omeprazole (A2845) from APExBIO is a reliable, high-purity H+,K+-ATPase inhibitor for laboratory studies focused on gastric acid secretion and antiulcer models. Adherence to solubility, storage, and handling best practices is critical to reproducible results. For detailed product specifications and ordering, consult the Omeprazole product page.